Drug & supplement interaction

Polypodium Leucotomos + Isatuximab-Irfc

Isatuximab-Irfc brand name: Sarclisa.

No Known Interaction
Medically reviewed by · Updated July 2026 · Pair last verified Sep 13, 2026
The bottom line No known interaction

We found no known interaction between Polypodium Leucotomos and Isatuximab-Irfc in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

Polypodium Leucotomos and Isatuximab-Irfc

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Isatuximab-Irfc and Polypodium Leucotomos in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Polypodium Leucotomos safety at a glance

Polypodium Leucoto... overall Use caution Generally well tolerated in studies, but long-term safety is not well established.
Pregnancy Avoid There is not enough safety data, so it is best avoided during pregnancy.
Breastfeeding Avoid Safety while breastfeeding is unknown, so avoidance is the safer choice.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Isatuximab-Irfc and Polypodium Leucotomos? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Keep it in perspective

Polypodium Leucotomos Does Interact With Other Medications

Polypodium Leucotomos has 643 minor known drug interactions in our database — Isatuximab-Irfc isn’t one of them. If you take anything else, check it against the full list below.

Minor 643 No known interaction 2,187 (incl. Isatuximab-Irfc)
Taking anything else?

Check Another of Your Medications Against Polypodium Leucotomos

Covers the 2,830 medications we’ve checked against Polypodium Leucotomos. Pick one to open its full report.

What to actually watch for

What Polypodium Leucotomos Itself Has Been Linked To

This is not an interaction — nothing below involves Isatuximab-Irfc. It is the side-effect record for Polypodium Leucotomos on its own, from the licensed Natural Medicines monograph. If something new turns up after you add Polypodium Leucotomos, this list is the first place to look.

  • Itching Additional detail

    “Orally, Polypodium leucotomos has rarely been associated with pruritus.”

    Polypodium Leucotomos · Natural Medicines adverse-effect record, reported in pruritus.

    1 source cited
    1. 101470. Goh CL, Chuah SY, Tien S, Thng G, Vitale MA, Delgado-Rubin A. Double-blind, placebo-controlled trial to evaluate the effectiveness of Polypodium leucotomos extract in the treatment of melasma in Asian skin: a pilot study. J Clin Aesthet Dermatol 2018;11(3

Everything above comes from the Natural Medicines adverse-effect record for Polypodium Leucotomos — expand a row for the licensed statement it rests on. We read the ADVERSE REACTIONS section of Isatuximab-Irfc’s FDA label too, and the two lists don’t meaningfully overlap — which is why no Isatuximab-Irfc column appears here.

Overlapping uses

What Isatuximab-Irfc Is Prescribed For, and What Polypodium Leucotomos Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Isatuximab-Irfc is a prescription medicine with approved uses on its FDA label. Polypodium Leucotomos is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Isatuximab-Irfc is prescribed for: Isatuximab-irfc injection is used to treat multiple myeloma (a cancer of plasma cells in the bone marrow) in adult patients. It is always given alongside other medicines — never alone. Sarclisa Escena (the subcutaneous form) is approved in three combinations: with pomalidomide and dexamethasone for patients who have had at least one prior treatment including lenalidomide and a proteasome inhibitor; with carfilzomib and dexamethasone for relapsed or refractory multiple myeloma after one to three prior treatments; and with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma in adults who are not eligible for an autologous stem cell transplant (a procedure using a patient's own stem cells). Intravenous isatuximab-irfc (Sarclisa) is used in the same combinations.

Polypodium Leucotomos has been studied for:

  • Cancer studied, not established Polypodium Leucotomos has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Polypodium Leucotomos for cancer

    Although there has been interest in using oral Polypodium leucotomos for cancer prevention, there is insufficient reliable information about the clinical effects of Polypodium leucotomos for this purpose.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Isatuximab-Irfc on your own; if you are taking Polypodium Leucotomos for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

One more smart check

Taking Polypodium Leucotomos as Part of a Dietary Supplement Product? Check It for Interactions

We hold 26 real supplement products containing Polypodium Leucotomos, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Polypodium Leucotomos. Even though Polypodium Leucotomos itself has no known interaction with Isatuximab-Irfc, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Polypodium Leucotomos and Isatuximab-Irfc Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Polypodium Leucotomos
Steady interest

#1,140 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Isatuximab-Irfc
Top half

#980 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Polypodium Leucotomos reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Polypodium Leucotomos and Isatuximab-Irfc records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Polypodium Leucotomos

What is Polypodium Leucotomos?

  • Sun sensitivity and sunburn protection
  • Skin conditions like vitiligo and melasma
  • Polymorphic light eruption
  • Skin aging and photoaging
  • Atopic dermatitis support

Polypodium leucotomos is a fern extract taken by mouth, mostly studied as an add-on to (not a replacement for) sunscreen and for certain light-triggered skin conditions. Some early research is promising for reducing sun sensitivity, but the evidence is still limited and it should not replace standard sun protection. Talk with your pharmacist or doctor before starting it.

Polypodium leucotomos · Polypodiaceae · Leaves (fronds) and rhizome extract · Capsules, tablets, oral supplements

An interaction check asks whether these two react with each other — it does not ask whether Polypodium Leucotomos is a good idea for someone in your situation. Here is what our Polypodium Leucotomos record says about it on its own.

Polypodium Leucotomos: dosing

There is no official or standardized dose for Polypodium leucotomos. Do not assume that taking more will give better or faster results.

From our Polypodium Leucotomos monograph — the full record covers uses, side effects and every documented interaction.

Read the full Polypodium Leucotomos monograph & all interactions
Medication

About Isatuximab-irfc Injection

What Is Isatuximab-irfc Injection Used For?

Brand name: Sarclisa

Isatuximab-irfc injection is used to treat multiple myeloma (a cancer of plasma cells in the bone marrow) in adult patients. It is always given alongside other medicines — never alone.

Sarclisa Escena (the subcutaneous form) is approved in three combinations: with pomalidomide and dexamethasone for patients who have had at least one prior treatment including lenalidomide and a proteasome inhibitor; with carfilzomib and dexamethasone for relapsed or refractory multiple myeloma after one to three prior treatments; and with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma in adults who are not eligible for an autologous stem cell transplant (a procedure using a patient's own stem cells). Intravenous isatuximab-irfc (Sarclisa) is used in the same combinations.

See full Isatuximab-irfc Injection drug information
Keep checking

Other Drugs & Polypodium Leucotomos

Browse every other medication we’ve checked against Polypodium Leucotomos — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
643Minor
2,186No known interaction
643 Minor 2,186 No interaction
Minor

643 interactions

Showing 60 of 643 minor interactions — see all 643 on the Polypodium Leucotomos page.

No interaction 2,186 drugs checked — show the list

We also checked Polypodium Leucotomos against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,186 medications checked with no known interaction — see the full Polypodium Leucotomos list.

See the full Polypodium Leucotomos interactions page
See every supplement checked against Isatuximab-Irfc, ranked by severity
Evidence & sources

Polypodium Leucotomos References

The 2 references that drive our Polypodium Leucotomos monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Goh CL, Chuah SY, Tien S, Thng G, Vitale MA, Delgado-Rubin A. Double-blind, placebo-controlled trial to evaluate the effectiveness of Polypodium leucotomos extract in the treatment of melasma in Asian skin: a pilot study. J Clin Aesthet Dermatol 2018;11(3
  2. Shinya K, Nishimura Y, Ryu K, et al. Short-term administration of Polypodium leucotomos extract does not inhibit CYP3A4-mediated metabolism of midazolam in healthy subjects: an open-label, two-period, fixed-sequence study. Int J Dermatol 2022.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Polypodium Leucotomos and Isatuximab-Irfc Together: Common Questions

Is it safe to take Polypodium Leucotomos with Isatuximab-Irfc?
We do not list a known interaction between Polypodium Leucotomos and Isatuximab-Irfc. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Are Polypodium Leucotomos and Isatuximab-Irfc used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Polypodium Leucotomos in each. That is a conversation for your prescriber, especially if Isatuximab-Irfc is being adjusted to a target.
Does Polypodium Leucotomos interact with any other medications?
Yes. Polypodium Leucotomos has 643 documented drug interactions in our database — Isatuximab-Irfc is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Polypodium Leucotomos monograph Uses, safety profile, and every drug interaction in one place Isatuximab-irfc Injection drug information The full plain-English guide to this medication Isatuximab-Irfc supplement interactions Every supplement checked against Isatuximab-Irfc, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 2 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Isatuximab-Irfc and Polypodium Leucotomos?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.